Phase 3 Study Investigating Ibrutinib In Younger CLL Patients - 101341

Spotlight
Video

Phase 3 Study Investigating Ibrutinib In Younger CLL Patients

obr has 715 videos Subscribe Here

Loading........
Description: Jeff Sharman, MD, Director of Research, Willamette Valley Cancer Institute, Medical Director of Hematology Research, The US Oncology Network, Discusses Phase 3 Study Investigating Ibrutinib In Younger CLL Patients. At The 60th ASH Annual Meeting on Dec 1, 2018. http://obroncology.com...
Shared By : obr
Posted on : 01/15/19
Added : 3 months ago